DJIA 16,514.24 12.59 0.08%
NASDAQ 4,152.62 25.65 0.62%
S&P 500 1,881.75 6.36 0.34%
market minute promo

BASF AG (ADR)

NASDAQOTH: BASFY

113.26 0.67 (0.59%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BASFY $113.26 0.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.12
Previous Close $112.59
Daily Range $111.16 - $113.63
52-Week Range $85.33 - $115.19
Market Cap $104.0B
P/E Ratio 32.63
Dividend (Yield) $0.00 (2.4%)
Volume 12,361
Average Daily Volume 32,058
Current FY EPS $7.89

Sector

Materials

Industry

Chemicals

BASF AG (ADR) (BASFY) Description

A global chemical company whose products include chemicals, plastics, coatings systems, dispersions, agricultural products, fine chemicals as well as crude oil and natural gas. Website:

News & Commentary Rss Feed

Innovation Is the Key Growth Driver for These Premium Sport Businesses

Nike, Adidas, and Under Armour are relying on innovation to drive their businesses forward. Nike, with a 1.10% dividend yield and a lower valuation than these peers, seems to be a good long-term stock for investors.

1 Biotech Buy-and-Hold Lesson Wall Street Wants to Forget

Wall Street panicked at the end of 2000 when Abbott Labs announced it was acquiring the pharmaceutical business of BASF. Shares sank 7.1% the next trading day on fears of dilution and a lack of execution. Turns out that was a great buying opportunity.

The “F” Word That’s Cleaning up Dirty Industries

It’s one of the most popular contamination cleansers in the world; businesses are using it in everything from swimming pools to coal mines.

The DAX Picks Up Steam as BASF and Siemens Look for New Growth

Germany's investments have grown after a lackluster start to the year, but BASF and Siemens are looking to the long run for gains

California’s Green Chemistry Initiative: Winners & Losers

California’s new law will have profound implications for consumer goods companies.

Will This Fishy Biotech Go Belly Up?

Will fish-oil treatment maker Amarin go belly up as generic versions of Lovaza, its primary competitor, are approved ahead of schedule?

1 Hidden Pharmaceutical Technology for Your Portfolio

A primer on the opportunity presented by biocatalysts.

Will Germany Finally Lead Europe Out of Recession?

Europe's been stuck in a rut for years, but economists are optimistic about the region's future growth prospects

Danger Looms at BASF and Siemens as Germany's DAX Falls

Germany's PMI ticks up, but many are doubtful that Europe's largest economy can save the faltering eurozone.

German Stocks Falter as European Crisis Fears Re-Emerge

Is the DAX in danger between Europe's debt crisis and Germany's lagging manufacturing?

See More BASFY News...

BASFY's Top Competitors

BASFY $113.26 (0.59%)
Current stock: BASFY
DD $67.27 (-0.10%)
Current stock: DD
POT $35.37 (0.65%)
Current stock: POT
MON $111.08 (-0.94%)
Current stock: MON